Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-30 Purchase |
2025-01-02 4:12 pm |
Galera Therapeutics Inc. | GRTX | CHANG NANCY T Director 10% Owner |
7,644,932 | $0.0654 | $499,979 | 7,646,774 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 4:45 pm |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
67,015 | $0.072 | $4,825 | 265,029 (Direct) |
View |
| 2014-04-17 Purchase(A) |
2024-05-01 5:02 pm |
Galera Therapeutics Inc. | GRTX | Schneid Yair 10% Owner |
2,780,407 | $0.21235 | $590,424 | 10,823,610 (Direct) |
View |
| 2024-01-11 Sale |
2024-04-01 9:36 pm |
Galera Therapeutics Inc. | GRTX | Altamont Pharmaceutical Holdings LLC Pearson Mark E. 10% Owner |
4,200,000 | $0.1933 | $811,848 | 1,080,000 (Indirect) |
View |
| 2024-01-29 Purchase |
2024-02-26 4:06 pm |
Galera Therapeutics Inc. | GRTX | Schneid Yair 10% Owner |
932,402 | $0.17848 | $166,417 | 8,043,203 (Direct) |
View |
| 2023-03-16 Purchase |
2023-03-20 4:05 pm |
Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer |
11,000 | $2.247 | $24,717 | 11,000 (Direct) |
View |
| 2023-03-10 Purchase |
2023-03-14 08:30 am |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
100,000 | $1.6812 | $168,120 | 332,044 (Direct) |
View |
| 2023-03-13 Purchase |
2023-03-14 08:30 am |
Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer |
10,000 | $1.9593 | $19,593 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-26 4:57 pm |
N/A 2035-02-23 |
Galera Therapeutics Inc. | GRTX | LOKAY KEVIN G Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 4:52 pm |
N/A 2035-02-23 |
Galera Therapeutics Inc. | GRTX | FRIEDMAN MICHAEL R. Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 4:46 pm |
N/A 2035-02-23 |
Galera Therapeutics Inc. | GRTX | CHANG NANCY T Director 10% Owner |
96,000 | $0 | 96,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 4:43 pm |
N/A 2035-02-23 |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2024-12-30 Option Award |
2025-01-02 4:12 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | CHANG NANCY T Director 10% Owner |
1,842 | $0 | 7,646,774 (Direct) |
View |
| 2024-12-30 Option Award |
2025-01-02 4:08 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | FRIEDMAN MICHAEL R. Director |
8,326 | $0 | 8,326 (Indirect) |
View |
Ownership |
2024-05-16 10:26 am |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Soffer Rochel ALPHA PHARMA Investments LLC 10% Owner |
0 | $0 | 5,928,137 (Direct) |
View |
Ownership |
2024-01-16 6:11 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Schneid Yair 10% Owner |
0 | $0 | 7,110,801 (Direct) |
View |
Ownership |
2023-11-13 2:22 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Altamont Pharmaceutical Holdings LLC Pearson Mark E. 10% Owner |
0 | $0 | 5,280,000 (Indirect) |
View |
| 2023-07-01 Option Award |
2023-07-05 4:19 pm |
N/A 2033-06-30 |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
22,762 | $0 | 22,762 (Direct) |
View |
| 2023-07-01 Option Award |
2023-07-05 4:11 pm |
N/A 2033-06-30 |
Galera Therapeutics Inc. | GRTX | West Linda Director |
23,382 | $0 | 23,382 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:15 pm |
N/A 2033-06-13 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:15 pm |
N/A 2033-06-13 |
Galera Therapeutics Inc. | GRTX | West Linda Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:15 pm |
N/A 2033-06-13 |
Galera Therapeutics Inc. | GRTX | LOKAY KEVIN G Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:15 pm |
N/A 2033-06-13 |
Galera Therapeutics Inc. | GRTX | Cunningham Emmett Director |
48,000 | $0 | 0 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:15 pm |
N/A 2033-06-13 |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 7:06 pm |
N/A 2033-02-24 |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 7:03 pm |
N/A 2033-02-24 |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
440,000 | $0 | 440,000 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 6:57 pm |
N/A 2033-02-24 |
Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer |
185,000 | $0 | 185,000 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 6:57 pm |
N/A 2033-02-24 |
Galera Therapeutics Inc. | GRTX | Kennedy Eugene P. Chief Medical Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 6:56 pm |
N/A 2033-02-24 |
Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-25 Option Award |
2023-02-28 6:56 pm |
N/A 2033-02-24 |
Galera Therapeutics Inc. | GRTX | Stacey Jennifer Evans See Remarks |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 4:05 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
10,000 | $1.07 | 183,842 (Direct) |
View |
| 2022-11-21 Exercise |
2022-11-22 4:05 pm |
N/A 2022-11-25 |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
10,000 | $0 | 183,842 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-13 4:10 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
10,000 | $1.07 | 183,842 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-13 4:10 pm |
N/A 2022-11-25 |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
10,000 | $0 | 183,842 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 4:15 pm |
N/A 2032-08-31 |
Galera Therapeutics Inc. | GRTX | Kennedy Eugene P. Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-07-18 Gift |
2022-07-20 06:05 am |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
4,000 | $0 | 10,370 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-05 4:05 pm |
N/A 2032-06-30 |
Galera Therapeutics Inc. | GRTX | West Linda Director |
58,496 | $0 | 58,496 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:06 pm |
N/A 2032-06-14 |
Galera Therapeutics Inc. | GRTX | LOKAY KEVIN G Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Galera Therapeutics Inc. | GRTX | West Linda Director |
15,000 | $0 | 15,000 (Direct) |
View |